DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) - Pipeline Review, H2 2016" report to their offering.
'Orexin Receptor Type 2 - Pipeline Review, H2 2016'; Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) pipeline Target constitutes close to 10 molecules. Out of which approximately 10 molecules are developed by Companies.
Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) Orexin receptor type 2 (Ox2R or OX2) also known as hypocretin receptor type 2, is a protein that is encoded by the HCRTR2 gene. OX2 is a G-protein coupled receptor expressed exclusively in the brain. OX2 binds both orexin A and orexin B neuropeptides. OX2 is involved in the central feedback mechanism that regulates feeding behavior.
The report 'Orexin Receptor Type 2 - Pipeline Review, H2 2016' outlays comprehensive information on the Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies
Universities.
It also reviews key players involved in Orexin Receptor Type 2 (Hypocretin Receptor Type 2 or HCRTR2) targeted therapeutics development, features dormant and discontinued projects and latest news and press releases. Currently, The molecules developed by Companies in Phase III, Phase II, Preclinical and Discovery stages are 1, 2, 4 and 3 respectively.
Key Topics Covered:
- Introduction
- Orexin Receptor Type 2 Overview
- Therapeutics Development
- Pipeline Products for Orexin Receptor Type 2 - Overview
- Pipeline Products for Orexin Receptor Type 2 - Comparative Analysis
- Orexin Receptor Type 2 - Therapeutics under Development by Companies
- Orexin Receptor Type 2 - Therapeutics under Investigation by Universities/Institutes
- Orexin Receptor Type 2 Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Orexin Receptor Type 2 - Products under Development by Companies
- Orexin Receptor Type 2 - Products under Investigation by Universities/Institutes
- Orexin Receptor Type 2 - Companies Involved in Therapeutics Development
- Eisai Co., Ltd.
- Evotec AG
- Heptares Therapeutics Limited
- Johnson & Johnson
- Merck & Co., Inc.
- Novartis AG
For more information about this report visit http://www.researchandmarkets.com/research/p3h258/orexin_receptor
